F-group (family)
3352.1.1.1 STT3
Ligands and drugs
135
Member domains
21
with ligand contacts (≤ 4 Å)
15.6% of members
16
with DrugDomain annotations
11.9% of members
6
with a DrugBank compound
4.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3352.1.1.1 belongs to X-group 3352 STT3/PglB/AglB transmembrane domain, which has 6 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02306 | CPL | Palmitoyl-Linoleoyl Phosphatidylcholine | 3 |
| DB00141 | NAG | N-Acetylglucosamine | 1 |
| DB04327 | PEE | Phosphatidylethanolamine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MNmetal | MANGANESE (II) ION | 6 |
| MGmetal | MAGNESIUM ION | 5 |
| 9UB | [(2~{S},3~{R},4~{R},5~{S},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl]methyl-[oxidanyl-[(2~{Z},6~{Z},10~{Z})-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoxy]phosphoryl]oxy-phosphinic acid | 4 |
| CPL | 1-PALMITOYL-2-LINOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 4 |
| EGY | (4R,7R)-4-hydroxy-N,N,N-trimethyl-4,9-dioxo-7-[(undecanoyloxy)methyl]-3,5,8-trioxa-4lambda~5~-phosphadocosan-1-aminium | 4 |
| ELU | phosphono [(3~{R},6~{E},10~{E})-3,7,11,15-tetramethylhexadeca-6,10,14-trienyl] hydrogen phosphate | 4 |
| KZB | (2~{S},3~{R},4~{R},5~{S},6~{S})-2-(hydroxymethyl)-6-[(1~{S},2~{R},3~{R},4~{R},5'~{S},6~{S},7~{R},8~{S},9~{R},12~{R},13~{R},15~{S},16~{S},18~{R})-5',7,9,13-tetramethyl-3,15-bis(oxidanyl)spiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane-6,2'-oxane]-16-yl]oxy-oxane-3,4,5-triol | 4 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 4 |
| 323 | 2-[3,6-bis(dimethylamino)xanthen-9-yl]-5-methanoyl-benzoate | 2 |
| NAmetal | SODIUM ION | 2 |
| 0K3 | (2Z,6Z,10Z,14Z,18Z,22Z,26Z)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl dihydrogen phosphate | 1 |
| 7E8 | (2R)-2,3-DIHYDROXYPROPYL (7Z)-TETRADEC-7-ENOATE | 1 |
| AJP | Digitonin | 1 |
| FFK | [(2~{R},3~{R},4~{R},5~{S},6~{R})-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-yl] [oxidanyl-[(2~{Z},6~{Z},10~{Z})-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoxy]phosphoryl] hydrogen phosphate | 1 |
| J06 | [(3S,6Z,10Z,14Z,18Z,22Z,26Z,30Z,34Z,39S,43S)-3,7,11,15,19,23,27,31,35,39,43,47-dodecamethyloctatetraconta-6,10,14,18,22,26,30,34-octaenyl] dihydrogen phosphate | 1 |
| KZE | [(3~{R},6~{Z},10~{Z},14~{Z},18~{Z})-3,7,11,15,19,23-hexamethyltetracosa-6,10,14,18,22-pentaenyl] dihydrogen phosphate | 1 |
| OTP | (2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-OCTAMETHYLDOTRIACONTA-2,6,10,14,18,22,26,30-OCTAENYL TRIHYDROGEN DIPHOSPHATE | 1 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 1 |
| V8K | Dolichylphosphate | 1 |
| ZNmetal | ZINC ION | 1 |